Tilray wins hands down in terms of stock price momentum. Over the last month, Tilray's share price has nearly quadrupled. Cronos Group and Canopy Growth have come close to doubling during the same period. Shares of Scotts Miracle-Gro, on the other hand, are down slightly.
MariMed focuses primarily on three aspects of the marijuana market. The company develops and operates medical cannabis production facilities that it leases to customers. MariMed provides professional consulting services to help businesses obtain state licenses to operate in the cannabis market. It also distributes its own lineup of cannabis products.
Kush Bottles, Inc. (OTCQB:KSHB) (“Kush Bottles” or the “Company”) a leading provider of packaging, supplies, vaporizers, hydrocarbon gases, solvents, accessories and branding solutions for the regulated cannabis industry, today reported financial results for its third quarter of 2018, for the period ended May 31, 2018.
One of the key U.S. Senate committees has recently stated that the Scheduling of cannabis from the federal level is impeding the amount of research that can be done into life-saving cures or treatments. This battle has been going on for some time now, but it now seems as though cannabis could have a louder voice amongst the U.S.
You might have thought that 2018 would have been a fantastic year for most marijuana stocks. Canada is on course to open its big recreational marijuana market in October. Global demand for medical marijuana is increasing. But the reality is that most marijuana stocks aren't performing nearly as well so far this year as they did at this point in 2017.
In what is being seen as a major boost for the legal marijuana industry, President Donald Trump has agreed to give the go-ahead to states to decide how to regulate marijuana.
For those coming in late, Attorney General Jeff Sessions had rescinded a memo that shielded marijuana operations from enforcement of the federal ban on marijuana in states that have legalized the drug.
Currently, marijuana is legal for medical use in 29 U.S. states, and for recreational use in eight states.
However, there is another top U.S. marijuana stock that could also be a big winner. Is now the time to think about buying Kush Bottles (NASDAQOTH:KSHB)?
Kush Bottles finds itself in a unique position. It definitely falls into the category of marijuana stock, since the company's core business is selling packaging and supplies to marijuana dispensaries and growers. But because Kush Bottles doesn't actually deal with marijuana itself, the company has access to capital that most industry players don't.
Whether the U.S. marijuana industry "only" doubles or more than triples in size over the next few years, there's one top stock that I think is especially poised to benefit from the growth: Scotts Miracle-Gro (NYSE:SMG). The reality is that there aren't many good choices for U.S. investors right now. Most U.S.-based marijuana stocks are penny stocks that come with risks including low liquidity levels.
With more states voting to legalize marijuana in some way, a new industry is emerging that is expected to reach $21.8 billion in sales by 2020. What was once seen as a "gateway drug" has become the catalyst for a multi-billion-dollar industry.
The U.S. cannabis market is estimated to be worth $6.7 billion. Canada's market is estimated to have hit $8 billion.
While the industry is still in its infancy, there is a huge potential for growth in the cannabis market. These five stocks look to be promising in 2018.
Beyond the Michigan news and Illinois’ Senate voting for cannabis to be considered as an alternative to opioids, this was a relatively tranquil week for weed.
“It feels like the cannabis industry needed a quiet week to recover from 420,” said Debra Borchardt, CEO and co-founder of Green Market Report. “There was some slightly positive news out of Washington DC where AG Jeff Sessions seemed to indicate he was open to the idea of more research for medical marijuana but still made sure everyone knew he wasn't going soft on cannabis just yet.